Annual EBITDA:
-$448.08M-$55.99M(-14.28%)Summary
- As of today, PCVX annual EBITDA is -$448.08 million, with the most recent change of -$55.99 million (-14.28%) on December 31, 2024.
- During the last 3 years, PCVX annual EBITDA has fallen by -$351.47 million (-363.79%).
- PCVX annual EBITDA is now -1479.25% below its all-time high of -$28.37 million, reached on December 31, 2018.
Performance
PCVX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$221.23M-$45.31M(-25.76%)Summary
- As of today, PCVX quarterly EBITDA is -$221.23 million, with the most recent change of -$45.31 million (-25.76%) on June 30, 2025.
- Over the past year, PCVX quarterly EBITDA has dropped by -$71.73 million (-47.98%).
- PCVX quarterly EBITDA is now -2037.07% below its all-time high of -$10.35 million, reached on June 30, 2019.
Performance
PCVX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$584.87M-$71.73M(-13.98%)Summary
- As of today, PCVX TTM EBITDA is -$584.87 million, with the most recent change of -$71.73 million (-13.98%) on June 30, 2025.
- Over the past year, PCVX TTM EBITDA has dropped by -$82.36 million (-16.39%).
- PCVX TTM EBITDA is now -4276.44% below its all-time high of -$13.36 million, reached on March 31, 2019.
Performance
PCVX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PCVX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -14.3% | -48.0% | -16.4% |
| 3Y3 Years | -363.8% | -377.2% | -329.5% |
| 5Y5 Years | -814.4% | -1008.1% | -616.0% |
PCVX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -363.8% | at low | -320.8% | at low | -252.4% | at low |
| 5Y | 5-Year | -814.4% | at low | -984.2% | at low | -616.0% | at low |
| All-Time | All-Time | -1479.3% | at low | -2037.1% | at low | -4276.4% | at low |
PCVX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$221.23M(-25.8%) | -$584.87M(-14.0%) |
| Mar 2025 | - | -$175.92M(-234.6%) | -$513.14M(-14.4%) |
| Dec 2024 | -$448.08M(-14.3%) | -$52.58M(+61.1%) | -$448.60M(+15.2%) |
| Sep 2024 | - | -$135.14M(+9.6%) | -$528.74M(-5.2%) |
| Jun 2024 | - | -$149.50M(-34.2%) | -$502.50M(-15.4%) |
| Mar 2024 | - | -$111.38M(+16.1%) | -$435.28M(-11.0%) |
| Dec 2023 | -$392.10M(-83.2%) | -$132.71M(-21.9%) | -$392.10M(-17.1%) |
| Sep 2023 | - | -$108.91M(-32.4%) | -$334.88M(-18.9%) |
| Jun 2023 | - | -$82.28M(-20.7%) | -$281.53M(-14.6%) |
| Mar 2023 | - | -$68.20M(+9.7%) | -$245.61M(-14.7%) |
| Dec 2022 | -$214.03M | -$75.49M(-35.9%) | -$214.10M(-29.0%) |
| Sep 2022 | - | -$55.56M(-19.9%) | -$165.97M(-21.9%) |
| Jun 2022 | - | -$46.36M(-26.3%) | -$136.16M(-20.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$36.69M(-34.1%) | -$112.61M(-14.3%) |
| Dec 2021 | -$96.61M(-10.0%) | -$27.36M(-6.2%) | -$98.54M(-7.6%) |
| Sep 2021 | - | -$25.76M(-13.0%) | -$91.58M(-5.9%) |
| Jun 2021 | - | -$22.80M(-0.8%) | -$86.51M(-3.4%) |
| Mar 2021 | - | -$22.62M(-10.8%) | -$83.67M(+4.7%) |
| Dec 2020 | -$87.81M(-79.2%) | -$20.41M(+1.3%) | -$87.81M(-7.5%) |
| Sep 2020 | - | -$20.68M(-3.6%) | -$81.68M(-13.4%) |
| Jun 2020 | - | -$19.96M(+25.4%) | -$72.00M(-15.4%) |
| Mar 2020 | - | -$26.75M(-87.3%) | -$62.39M(-27.3%) |
| Dec 2019 | -$49.00M(-72.7%) | -$14.28M(-29.8%) | -$49.00M(-41.1%) |
| Sep 2019 | - | -$11.00M(-6.3%) | -$34.72M(-46.4%) |
| Jun 2019 | - | -$10.35M(+22.5%) | -$23.72M(-77.5%) |
| Mar 2019 | - | -$13.36M | -$13.36M |
| Dec 2018 | -$28.37M | - | - |
FAQ
- What is Vaxcyte, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. annual EBITDA year-on-year change?
- What is Vaxcyte, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. quarterly EBITDA year-on-year change?
- What is Vaxcyte, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Vaxcyte, Inc.?
- What is Vaxcyte, Inc. TTM EBITDA year-on-year change?
What is Vaxcyte, Inc. annual EBITDA?
The current annual EBITDA of PCVX is -$448.08M
What is the all-time high annual EBITDA for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high annual EBITDA is -$28.37M
What is Vaxcyte, Inc. annual EBITDA year-on-year change?
Over the past year, PCVX annual EBITDA has changed by -$55.99M (-14.28%)
What is Vaxcyte, Inc. quarterly EBITDA?
The current quarterly EBITDA of PCVX is -$221.23M
What is the all-time high quarterly EBITDA for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high quarterly EBITDA is -$10.35M
What is Vaxcyte, Inc. quarterly EBITDA year-on-year change?
Over the past year, PCVX quarterly EBITDA has changed by -$71.73M (-47.98%)
What is Vaxcyte, Inc. TTM EBITDA?
The current TTM EBITDA of PCVX is -$584.87M
What is the all-time high TTM EBITDA for Vaxcyte, Inc.?
Vaxcyte, Inc. all-time high TTM EBITDA is -$13.36M
What is Vaxcyte, Inc. TTM EBITDA year-on-year change?
Over the past year, PCVX TTM EBITDA has changed by -$82.36M (-16.39%)